VJET on NYSE

Flyte Aviation, Inc.

American surgical and medical instruments and apparatus company.

Price unavailable

Last updated Oct 18, 2026.

Overview

Compare with Harvard Apparatus Regenerative Technology, Inc., Sintx Technologies, Inc. or Co-Diagnostics, Inc., or pick any stock.

  • TickerVJET on NYSE
  • IndustrySurgical & Medical Instruments & Apparatus
  • HeadquartersDE
  • Incorporated inDE2
  • Business address1670 Highway 160 West, Suite 205, Fort Mill, Sc 297082
  • Filer categoryNon-accelerated filer, Smaller reporting company2

See how the biggest companies compare on our leaderboards

Financials

From the company’s reports to the SEC. Every number links to the filing it came from.

Key numbers, fiscal 2025

92.3%Gross margin3
-2581.6%Operating margin3
-2098.0%Net margin3
95.0%Revenue growth, 20253
-243.6%Return on equity3
0.44×Debt to equity3
-$8.3MFree cash flow3

Where the money goes

Where each dollar of revenue went, fiscal 2025

  • Cost of revenue0¢$63.0K
  • Selling, general and admin87¢$12.1M
  • Income tax13¢$1.8M

Out of $819.0K in revenue.3 The company lost money this year.

Financial statements

Revenue45673$819.0K in 2025−89% since 2019
0$2.0M$4.0M$6.0M$8.0M2019: $7.2M$7.2M20192020: $259.0K$259.0K2020−96%2021: $22.0K$22.0K2021−92%2022: $14.0K$14.0K2022−36%2023: $442.0K$442.0K2023+3057%2024: $420.0K$420.0K2024−5%2025: $819.0K$819.0K2025+95%
Gross profit456873$756.0K in 2025
-$2.0M-$1.0M0$1.0M2019: -$1.7M-$1.7M20192020: -$1.9M-$1.9M2020+16%2021: -$1.5M-$1.5M2021−20%2022: -$147.0K-$147.0K2022−90%2023: $412.0K$412.0K20232024: $378.0K$378.0K2024−8%2025: $756.0K$756.0K2025+100%
Operating income456873-$21.1M in 2025−63% since 2019
-$80.0M-$60.0M-$40.0M-$20.0M02019: -$57.7M-$57.7M20192020: -$35.4M-$35.4M2020−39%2021: -$29.3M-$29.3M2021−17%2022: -$27.0M-$27.0M2022−8%2023: -$78.1M-$78.1M2023+190%2024: -$11.2M-$11.2M2024−86%2025: -$21.1M-$21.1M2025+88%
Net income456873-$17.2M in 2025−70% since 2019
-$80.0M-$60.0M-$40.0M-$20.0M02019: -$57.0M-$57.0M20192020: -$36.0M-$36.0M2020−37%2021: -$25.1M-$25.1M2021−30%2022: -$26.9M-$26.9M2022+7%2023: -$70.6M-$70.6M2023+163%2024: -$16.6M-$16.6M2024−76%2025: -$17.2M-$17.2M2025+3%
Fiscal year2019202020212022202320242025
Revenue$7.2M4$259.0K5$22.0K6$14.0K6$442.0K7$420.0K3$819.0K3
Cost of revenue$8.8M4$5.5M4$1.6M6$161.0K8$30.0K8$42.0K3$63.0K3
Gross profit-$1.7M4-$1.9M5-$1.5M6-$147.0K8$412.0K7$378.0K3$756.0K3
Research and development$4.5M4$9.0M5$12.3M6$6.4M8$475.0K7$272.0K7
Selling, general and admin$51.5M4$24.5M5$15.5M6$16.2M8$17.1M7$11.3M3$12.1M3
Operating income-$57.7M4-$35.4M5-$29.3M6-$27.0M8-$78.1M7-$11.2M3-$21.1M3
Interest$250.0K4$108.0K4
Income tax$15.0K4$7.0K5$4.0K6$3.0K8$07$3.1M3-$1.8M3
Net income-$57.0M4-$36.0M5-$25.1M6-$26.9M8-$70.6M7-$16.6M3-$17.2M3
Earnings per share-$248.226-$25.986-$129.887-$126.913-$15.903
Earnings per share (diluted)-$248.226-$25.986

Compare Flyte Aviation, Inc. with another company

Leadership

Who has led Flyte Aviation, Inc., and when. Pick a name to see everywhere that person has worked.

Chief executive

  1. Andrew C. Jackson2019
  2. Jonathan Will McGuire2020–2023

President

  1. Jeffrey J. Kraws2018–2020

Chief financial officer

  1. Andrew C. Jackson2018–2022
  2. Brian Conn2022
  3. Steven K. Passey2023
  4. Margrit Thomassen2024
  5. Philip J. Anderson2025–now
20202025
Board members and other officers (17)

Former names

  • Catheter Precision, Inc.Aug 25, 2023 to Oct 2, 20262
  • Ra Medical Systems, Inc.Sep 20, 2017 to Aug 15, 20232

Timeline

  1. Apr 1, 2020New chief executive Jonathan Will McGuire becomes CEO12
  2. Dec 5, 2019New chief executive Andrew C. Jackson becomes CEO13

Filings

355 filings to the SEC since October 2021: 8 annual reports, 15 quarterly reports, 116 major events, 47 insider forms, 22 large holders, 2 private raises, 145 other. The latest 20:

  1. Oct 14, 20268-K EDGAR
  2. Oct 13, 20268-K EDGAR
  3. Oct 9, 20268-K EDGAR
  4. Oct 5, 20268-K EDGAR
  5. Oct 2, 20268-K EDGAR
  6. Sep 25, 20268-K EDGAR
  7. Aug 31, 2026DEF 14A EDGAR
  8. Aug 21, 2026424B3 EDGAR
  9. Aug 21, 2026PRE 14A EDGAR
  10. Aug 21, 2026SCHEDULE 13G EDGAR
  11. Aug 14, 202610-Q EDGAR
  12. Jul 31, 20268-K EDGAR
  13. Jul 29, 20268-K/A EDGAR
  14. Jul 20, 2026SCHEDULE 13G EDGAR
  15. Jul 15, 20268-K EDGAR
  16. Jul 10, 2026EFFECT EDGAR
  17. Jul 10, 2026424B3 EDGAR
  18. Jul 6, 2026S-1/A EDGAR
  19. Jun 26, 2026SCHEDULE 13G EDGAR
  20. Jun 22, 2026S-1 EDGAR

The 355 filings since October 2021 can be filtered by form type and year here when JavaScript is on.

Every filing from the last three years, summarized. The full record is on SEC EDGAR.

Insider trades and holders

Large holders

Investors who own more than 5% must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively. 22 such filings since October 2021, the latest 10:

  1. Aug 21, 2026SCHEDULE 13G
  2. Jul 20, 2026SCHEDULE 13G
  3. Jun 26, 2026SCHEDULE 13G
  4. May 14, 2026SCHEDULE 13G/A
  5. Feb 13, 2026SCHEDULE 13G
  6. Feb 11, 2026SCHEDULE 13G
  7. Feb 11, 2026SCHEDULE 13G
  8. Aug 14, 2025SCHEDULE 13G/A
  9. May 15, 2025SCHEDULE 13G/A
  10. Feb 14, 2025SCHEDULE 13G/A

From Forms 4 and Schedules 13D and 13G filed with the SEC.

Money raised

Private offerings the company reported to the SEC on Form D.

  1. Mar 23, 2023Raised $8 million in a private offering of equity Form D: 1 investor so far Form D
  2. Jul 22, 2022Raised $6.2 million in a private offering of equity Form D: 14 investors so far Form D

Sources

The numbers on this page point here. Each one links to the record it came from.

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20
  21. 21
  22. 22
  23. 23
  24. 24
  25. 25
  26. 26
  27. 27
  28. 28
  29. 29
  30. 30
  31. 31
  32. 32
  33. 33